The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers

Yujing Zhang, Cai Yulan, Kaiguo Long, Qi Wang, Chuyu Liu, Feng Zeng

Open source

DOI
10.3389/fonc.2026.1962446
Published
2026-10-22
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1962446,
  title = {The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers},
  author = {Yujing Zhang and Cai Yulan and Kaiguo Long and Qi Wang and Chuyu Liu and Feng Zeng},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1962446},
  url = {https://doi.org/10.3389/fonc.2026.1962446}
}

RIS

TY  - JOUR
TI  - The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers
AU  - Yujing Zhang
AU  - Cai Yulan
AU  - Kaiguo Long
AU  - Qi Wang
AU  - Chuyu Liu
AU  - Feng Zeng
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1962446
UR  - https://doi.org/10.3389/fonc.2026.1962446
ER  - 

APA

Zhang, Y., Yulan, C., Long, K., Wang, Q., Liu, C., & Zeng, F. (2026). The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1962446

Source records